Skip To Main Content
Oyinade Aderibigbe on Muck Rack

Oyinade Aderibigbe

As seen in: JAMA (The Journal of the American Medical Association)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Oyinade

Contact Oyinade, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Potential Role of Tranexamine Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation-Reply

|
By Roopal V. Kundu, Neelam A. Vashi, Oyinade Aderibigbe, Julia Riley
| JAMA (The Journal of the American Medical Association) Verified
Potential Role of Tranexamine Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation—Reply In Reply We thank Hashemi et al for their engagement and thoughtful reply to our article1 that highlighted their experience with tranexamic acid (TA) and procedural therapies. We agree that treatment approaches in hyperpigmentation have had great advancements.
Open in Who Shared Issue with article?

Managing Facial Hyperpigmentation

|
By Roopal V. Kundu, Julia Riley, Oyinade Aderibigbe
| JAMA (The Journal of the American Medical Association) Verified
Hyperpigmentation is a common cutaneous concern in individuals with skin of color,1 often leading to psychosocial distress.2 Given the lack of rigorous clinical studies, expert opinion guides accepted treatment algorithms. Acquired facial hyperpigmentation commonly presents as melasma or postinflammatory hyperpigmentation (PIH).
Open in Who Shared Issue with article?
See all 2 articles